virus
Showing 1 - 25 of >10,000
Ebola Virus Disease Trial in Kenema (rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO))
Not yet recruiting
- Ebola Virus Disease
- rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO)
-
Kenema, Eastern, Sierra LeoneKenema Government Hospital
Aug 7, 2023
Malignant Tumor Trial in Chengdu (Oncolytic Virus SDJ001, Oncolytic Virus YD06-1)
Recruiting
- Malignant Tumor
- Oncolytic Virus SDJ001
- Oncolytic Virus YD06-1
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 6, 2023
Respiratory Syncytial Virus Disease in Infants and Toddlers
Not yet recruiting
- Respiratory Syncytial Virus Infections
- (no location specified)
Jul 27, 2023
Seroconversion of Hepatitis c Virus Among CKD on Regular
Not yet recruiting
- Hepatitis C Virus
- (no location specified)
Oct 25, 2023
Respiratory Syncytial Virus Infection Trial (Sisunatovir, Placebo)
Not yet recruiting
- Respiratory Syncytial Virus Infection
- Sisunatovir
- Placebo
- (no location specified)
Oct 6, 2023
Interaction Between Hepatitis C Virus Infection and Pregnancy
Enrolling by invitation
- Hepacivirus
- Pregnancy
- HCV infection status
-
Beijing, ChinaBeijing Ditan Hospital
Jun 24, 2023
Immune Function and PD-1 Antibody Therapy Efficacy Predictors on
Recruiting
- Secondary Hemophagocytic Lymphohistiocytosis
- Chronic Active Epstein-Barr Virus Infection
- No intervention
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
May 2, 2023
Respiratory Syncytial Virus Infections Trial in Saint Petersburg (RSV/Flu-01E low dose, RSV/Flu-01E high dose, Placebo)
Active, not recruiting
- Respiratory Syncytial Virus Infections
- RSV/Flu-01E low dose
- +2 more
-
Saint Petersburg, Russian FederationSmorodintsev Research Institute of Influenza
Jul 24, 2023
Chikungunya Virus Infection Trial (VLA1553)
Not yet recruiting
- Chikungunya Virus Infection
- VLA1553
- (no location specified)
Aug 31, 2023
Chronic Hepatitis Delta Virus Infection Trial (HH-003(20mg/kg), HH-003(10mg/kg), TAF)
Not yet recruiting
- Chronic Hepatitis Delta Virus Infection
- HH-003(20mg/kg)
- +2 more
- (no location specified)
May 7, 2023
Multiple Sclerosis Trial in Boston (Truvada (tenofovir/emtricitabine))
Enrolling by invitation
- Multiple Sclerosis
- Truvada (tenofovir/emtricitabine)
-
Boston, MassachusettsMassachusetts General Hospital
Jul 14, 2023
Marburg Virus Disease Trial in Siaya, Kampala (cAd3-Marburg vaccine, Placebo)
Not yet recruiting
- Marburg Virus Disease
- cAd3-Marburg vaccine
- Placebo
-
Siaya, Kenya
- +1 more
Apr 17, 2023
Dengue Trial in Syracuse (Dengue virus 1 Live Virus Human Challenge (DENV-1-LVHC), Dengue virus 3 Live Virus Human Challenge
Not yet recruiting
- Dengue
- Dengue virus 1 Live Virus Human Challenge (DENV-1-LVHC)
- Dengue virus 3 Live Virus Human Challenge (DENV-3-LVHC)
-
Syracuse, New YorkState University of New York, Upstate Medical University (SUNY-U
Jul 28, 2023
Epstein Barr Virus Infection in Radiologically Isolated Syndrome
Recruiting
- Multiple Sclerosis
- +2 more
- NO INTERVENTION
-
Nice, FranceNice University Hospital
Apr 3, 2023
Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection Trial in Houston (Virus-specific Cytotoxic T-lymphocytes)
Recruiting
- Adenovirus Infection
- +6 more
- Virus-specific Cytotoxic T-lymphocytes
-
Houston, TexasM D Anderson Cancer Center
Jan 6, 2023
Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))
Recruiting
- Sarcoma
- +9 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Linyi, Shandong, ChinaLinyi Central Hospital
Jul 25, 2023
Early Detection of Epstein-Barr Virus Related Disease.
Active, not recruiting
- Post-transplant Lymphoproliferative Disorder
- +8 more
-
Aarhus, Central Region Of Denmark, DenmarkAarhus University Hospital
Dec 12, 2022
Anal Fissure Among Survivors of COVID-19 Virus Infection.
Completed
- Anal Fissure
- Corona Virus Infection
-
Mansoura, EgyptAhmad
Feb 22, 2023
Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))
Recruiting
- Sarcoma
- +8 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, Jiangsu, ChinaXuzhou Second People's Hospital
May 8, 2023
Ebola Virus Disease Trial in Goma, Kinshasa (Zabdeno® booster, Ervebo® booster)
Not yet recruiting
- Ebola Virus Disease
- Zabdeno® booster
- Ervebo® booster
-
Goma, Congo, The Democratic Republic of the
- +1 more
Nov 6, 2023
Cervical Cancer, Endometrial Cancer, Advanced Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type ?
Recruiting
- Cervical Cancer
- +2 more
- Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
Mar 31, 2023
Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))
Recruiting
- Osteosarcoma
- +3 more
- Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
-
Xi'an, Shaanxi, ChinaXi'an Honghui Hospital
May 8, 2023
Self-Collected Swabs for Primary Human Papilloma Virus Screening
Not yet recruiting
- HPV
- Self-swab for genital HPV
- (no location specified)
Aug 9, 2023